Hypogonadotrophic Hypogonadism in Genetic Neurodevelopmental Conditions
NCT07049042 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 50
Last updated 2025-07-03
Summary
Hypogonadism is the medical name for a condition in which levels of the hormones which control sexual development are lower than normal. There are dozens of different causes of hypogonadism. Many people with hypogonadism have a change in a gene. There are many genes that give instructions for the hormones important for sexual development. Changes in one of these genes that stops the gene from working, can cause hypogonadism. In some of these medical conditions, there are additional features such as learning problems. In this study we will search databases to find all the genetic conditions that can be associated with hypogonadism. We will ask a number of people with changes in certain genes, identified from our search, to come to our research clinic. We will ask them about their health and examine them for signs of hypogonadism. For some, we will take blood samples to test for hypogonadism. This project will help us understand how common hypogonadism is, in people with these genetic changes, which will help with their treatment.
Conditions
- Genetic Neurodevelopmental Disorders
Sponsors & Collaborators
-
University of Sheffield
lead OTHER
Eligibility
- Min Age
- 0 Years
- Max Age
- 99 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-01-08
- Primary Completion
- 2029-05-01
- Completion
- 2029-05-01
Countries
- United Kingdom
Study Locations
More Related Trials
-
Endocrine Dysfunction and Growth Hormone Deficiency in Children With Optic Nerve Hypoplasia
NCT00140413 ·Status: COMPLETED ·Phase: PHASE4
-
Growth Hormone Treatment of Young Growth Hormone-Deficient Adults
NCT00187993 ·Status: UNKNOWN
-
Effects of Growth Hormone on Cognition and Cerebral Metabolism in Adults With Growth Hormone Deficiency
NCT01007071 ·Status: COMPLETED ·Phase: PHASE3
-
Human Menopausal Gonadotropin Combining With Human Chorionic Gonadotropin Treat Congenital Hypogonadotropic Hypogonadism
NCT02880280 ·Status: UNKNOWN ·Phase: PHASE4
-
Study of Skeletal Disorders and Short Stature
NCT00001754 ·Status: COMPLETED
-
Treatment Of Children With Short Stature At An Age Of 3-7 Years Who Were Born Small For Gestational Age
NCT00174408 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment With Recombinant Human Growth Hormone (GH) in Children With Short Stature Secondary to a Long Term Corticoid Therapy
NCT00174187 ·Status: TERMINATED ·Phase: PHASE3
-
Growth Hormone Therapy in Osteogenesis Imperfecta
NCT00001305 ·Status: COMPLETED ·Phase: PHASE3
-
Drug Use Investigation of Somatropin for GHD-ADULTS.
NCT00601419 ·Status: COMPLETED
-
Treatment With Recombinant Human Growth Hormone Genotonorm (Registered) In Children With Short Stature Secondary
NCT00174278 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment Of Short Stature With Genotropin In Children Born Small For Gestational Age Until Final Height
NCT00174421 ·Status: COMPLETED ·Phase: PHASE3
-
Hormone Treatment in Growth Hormone and Testosterone Deficient Patients
NCT01397500 ·Status: TERMINATED ·Phase: PHASE2
-
Evolution Of Growth Rate In Children With Growth Retardation Due to Glucocorticosteroid Therapy And Treated By Genotonorm
NCT00163189 ·Status: COMPLETED ·Phase: PHASE3
-
Quality of Life and Psychosocial Dimension in Children With Hypopituitarism
NCT05403255 ·Status: UNKNOWN
-
Genotropin Treatment in Short Prepubertal Children With Intra-Uterine Growth Retardation
NCT01073605 ·Status: COMPLETED ·Phase: PHASE3
-
COPENHAGEN Minipuberty Study
NCT02784184 ·Status: UNKNOWN
-
Detection and Treatment of Endocrine Abnormalities in Childhood Cancer Survivors and Hematopoietic Stem Cell Transplant Recipients
NCT00504218 ·Status: TERMINATED
-
Consequence of Lifetime Isolated Growth Hormone Deficiency
NCT00149708 ·Status: COMPLETED ·Phase: NA
-
Effects of Growth Hormone (GH) Deficiency and Growth Hormone Replacement on Serum Fibroblast Growth Factor 21 (FGF21)
NCT02243852 ·Status: WITHDRAWN
-
A Study of the Genetic Basis of Response to Growth Hormone Treatment in Children With Idiopathic Short Stature
NCT05894876 ·Status: TERMINATED
-
Health Needs of Patients With Kallmann Syndrome
NCT01914172 ·Status: COMPLETED
-
Natural History Study of Patients With Excess Androgen
NCT00250159 ·Status: RECRUITING
-
Effect of Pegvisomant on GH/IGF-I Relationship in GHD
NCT00468624 ·Status: TERMINATED ·Phase: NA
-
Effects of GH on Body Proportions and Final Height in X-Linked Hypophosphatemic Rickets
NCT00473187 ·Status: UNKNOWN ·Phase: PHASE1
-
A Real World Study of the Effect of Early PEG-rhGH Therapy on Cognitive Development of SGA Infants
NCT05144035 ·Status: RECRUITING ·Phase: PHASE4